ArticleJournal of hematology & oncology2016

Synergistic effect of oridonin and a PI3K/mTOR inhibitor on the non-germinal center B cell-like subtype of diffuse large B cell lymphoma.

Kai Qing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.